Explained — Why Sun Pharma shares are down 5% in a strong market
Shares of Sun Pharmaceuticals Industries Ltd. declined on Friday, April 10, as the company has decided to proceed with the bid for the acquisition of the US-based pharma firm Organon with a binding offer of $12 billion, as per reports. Sun Pharma is said to have completed the due diligence that lasted over three months…
